A Review of Ongoing Trials to Treat COVID-19
Year: 2020
Type: article
Abstract: The SARS-CoV-2 infection rose in December 2019 and afterward spread quickly around the world, especially to China, Japan and South Korea.Researchers are attempting to discover antivirals explicit to the infection.Some drugs Such as arbidol, chloroquine, remdesivir and favipiravir are right as of now experiencing clinical evaluations to test their sensibility and security in the treatment of coronavirus disease 2019 (COVID-19) in China, some consoling results have been developed up until now.This article sums up specialists with expected viability against SARS-CoV-2.
Source: ACTA SCIENTIFIC MICROBIOLOGY
Authors: Anirban Adhikary, Kakoli Halder, Debmalya Ghosh, Snehansu Biswas, Indranil Chatterjee, Suman Kumar Nath
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W3095686128